YTEN
Income statement / Annual
Last year (2023), Yield10 Bioscience, Inc.'s total revenue was $60.00 K,
a decrease of 86.67% from the previous year.
In 2023, Yield10 Bioscience, Inc.'s net income was -$14.46 M.
See Yield10 Bioscience, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$60.00 K |
$450.00 K |
$614.00 K |
$799.00 K |
$806.00 K |
$556.00 K |
$944.00 K |
$1.16 M |
$2.59 M |
$2.80 M |
| Cost of Revenue |
$290.00 K
|
$656.00 K
|
$578.00 K
|
$5.22 M
|
$4.85 M
|
$4.78 M
|
$4.60 M
|
$5.67 M
|
$660.00 K
|
$1.48 M
|
| Gross Profit |
-$230.00 K
|
-$206.00 K
|
$36.00 K
|
-$4.42 M
|
-$4.04 M
|
-$4.23 M
|
-$3.65 M
|
-$4.51 M
|
$1.93 M
|
$1.32 M
|
| Gross Profit Ratio |
-3.83
|
-0.46
|
0.06
|
-5.53
|
-5.01
|
-7.6
|
-3.87
|
-3.89
|
0.75
|
0.47
|
| Research and Development Expenses |
$8.32 M
|
$7.75 M
|
$6.20 M
|
$5.36 M
|
$4.85 M
|
$4.78 M
|
$4.60 M
|
$5.67 M
|
$16.57 M
|
$17.34 M
|
| General & Administrative Expenses |
$6.15 M
|
$6.15 M
|
$6.11 M
|
$5.05 M
|
$4.55 M
|
$5.09 M
|
$5.63 M
|
$5.74 M
|
$9.11 M
|
$10.81 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.15 M
|
$6.15 M
|
$6.11 M
|
$5.05 M
|
$4.55 M
|
$5.09 M
|
$5.63 M
|
$5.74 M
|
$9.11 M
|
$10.81 M
|
| Other Expenses |
$0.00
|
$41.00 K
|
-$3.00 K
|
$83.00 K
|
$21.00 K
|
$134.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$14.48 M
|
$13.90 M
|
$12.31 M
|
$10.41 M
|
$9.40 M
|
$9.88 M
|
$10.23 M
|
$11.41 M
|
$25.68 M
|
$28.15 M
|
| Cost And Expenses |
$14.48 M
|
$13.90 M
|
$12.31 M
|
$10.41 M
|
$9.40 M
|
$9.88 M
|
$10.23 M
|
$11.41 M
|
$26.34 M
|
$29.63 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$96.00 K
|
$158.00 K
|
$0.00
|
$0.00
|
$5.00 K
|
$7.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$13.02 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$290.00 K
|
$656.00 K
|
$578.00 K
|
$611.00 K
|
$1.83 M
|
$784.00 K
|
$206.00 K
|
$177.00 K
|
$265.00 K
|
$507.00 K
|
| EBITDA |
-$14.13 M |
-$13.19 M |
-$11.47 M |
-$9.43 M |
-$8.39 M |
-$9.12 M |
-$9.08 M |
-$10.07 M |
-$12.35 M |
-$26.32 M |
| EBITDA Ratio |
-235.45
|
-29.31
|
-18.68
|
-11.8
|
-10.41
|
-16.41
|
-9.62
|
-8.69
|
-4.76
|
-9.4
|
| Operating Income Ratio |
-240.28
|
-29.89
|
-19.04
|
-12.03
|
-10.67
|
-16.76
|
-9.83
|
-8.84
|
-9.15
|
-9.58
|
| Total Other Income/Expenses Net |
-$38.00 K
|
$41.00 K
|
$697.00 K
|
-$541.00 K
|
-$4.61 M
|
$134.00 K
|
-$113.00 K
|
-$38.00 K
|
$29.00 K
|
$61.00 K
|
| Income Before Tax |
-$14.46 M
|
-$13.41 M
|
-$11.00 M
|
-$10.15 M
|
-$13.21 M
|
-$9.19 M
|
-$9.40 M
|
-$10.29 M
|
-$23.68 M
|
-$26.77 M
|
| Income Before Tax Ratio |
-240.92
|
-29.8
|
-17.91
|
-12.7
|
-16.39
|
-16.52
|
-9.95
|
-8.87
|
-9.13
|
-9.56
|
| Income Tax Expense |
$0.00
|
$156.00 K
|
$36.00 K
|
$56.00 K
|
-$254.00 K
|
$0.00
|
$0.00
|
-$1.10 M
|
-$62.00 K
|
$0.00
|
| Net Income |
-$14.46 M
|
-$13.57 M
|
-$11.03 M
|
-$10.21 M
|
-$12.96 M
|
-$9.19 M
|
-$9.40 M
|
-$7.60 M
|
-$23.68 M
|
-$29.53 M
|
| Net Income Ratio |
-240.92
|
-30.15
|
-17.97
|
-12.77
|
-16.07
|
-16.52
|
-9.95
|
-6.56
|
-9.13
|
-10.55
|
| EPS |
-43.66 |
-66.25 |
-55.95 |
-103.21 |
-851.98 |
-887.78 |
-2771.06 |
-2651.74 |
-9184.37 |
-27966.3 |
| EPS Diluted |
-43.66 |
-66.25 |
-55.95 |
-103.21 |
-851.98 |
-887.78 |
-2771.06 |
-2651.74 |
-9184.37 |
-27966.3 |
| Weighted Average Shares Out |
$331.10 K
|
$204.77 K
|
$197.16 K
|
$98.89 K
|
$15.21 K
|
$10.35 K
|
$3.39 K
|
$2.87 K
|
$2.58 K
|
$1.06 K
|
| Weighted Average Shares Out Diluted |
$331.10 K
|
$204.77 K
|
$197.16 K
|
$98.89 K
|
$15.21 K
|
$10.35 K
|
$3.39 K
|
$2.87 K
|
$2.58 K
|
$1.06 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
